Monkeypox (mpox) Diagnosis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research has recently published an extensive report on the global Monkeypox (Mpox) Diagnosis Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

Monkeypox Diagnosis Market Size (2024E): USD 1.95 Bn
Projected Market Value (2031F): USD 2.4 Bn
Global Market Growth Rate (CAGR 2024 to 2031): 4.4%

Monkeypox Diagnosis Market - Report Scope:

The Monkeypox (Mpox) Diagnosis Market encompasses various diagnostic tools used to detect the presence of the monkeypox virus. With the resurgence of monkeypox outbreaks, especially in 2022-2023, diagnostic solutions have gained significant importance. Testing methods range from real-time PCR to point-of-care solutions, and these diagnostic tools are used in hospitals, clinics, laboratories, and home-based settings. The market's growth is driven by advancements in molecular diagnostics, rising global awareness, and the integration of monkeypox testing into broader infectious disease panels.

Market Growth Drivers:

The global Monkeypox Diagnosis Market is driven by multiple key factors, including heightened global awareness and enhanced surveillance following the 2022 outbreak. Governments and healthcare organizations worldwide have prioritized early detection, investing in diagnostic infrastructure to control the spread of the virus. Technological advancements, such as real-time PCR and point-of-care solutions, have made testing more accessible and efficient, especially in regions with limited diagnostic capabilities. Additionally, the integration of monkeypox testing into multiplex infectious disease panels and the growing demand for rapid, accessible solutions are accelerating market growth.

Market Restraints:

Despite the growing demand, the Monkeypox Diagnosis Market faces several challenges. Limited awareness and testing infrastructure in developing regions hinder market expansion, as many areas lack the necessary healthcare facilities and trained personnel. Furthermore, regulatory and compliance challenges create barriers to market entry, delaying the introduction of new diagnostic tools and limiting the adoption of innovative technologies. These factors can impede market growth, particularly in regions where healthcare priorities and public health funding are limited.

Market Opportunities:

The Monkeypox Diagnosis Market offers substantial opportunities, particularly through the expansion of point-of-care testing (POCT). The demand for rapid, decentralized diagnostic solutions is rising, particularly in resource-limited regions. The development of portable, easy-to-use diagnostic kits that deliver accurate results within minutes presents a transformative opportunity for the market. These advancements enable faster identification and containment of outbreaks, providing more efficient healthcare resource allocation. Moreover, the integration of monkeypox testing into routine healthcare protocols and broader infectious disease panels is set to drive future market growth.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the Monkeypox (Mpox) Diagnosis Market globally?
How are technological advancements influencing the competitive landscape of the Monkeypox Diagnosis Market?
What are the emerging trends and future prospects in the global Monkeypox Diagnosis Market?
Which diagnostic tests are leading in adoption across various healthcare settings?
How are leading players capitalizing on opportunities in the Monkeypox Diagnosis Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Monkeypox Diagnosis Market focus on technological innovations and strategic partnerships to gain a competitive edge. Companies are investing in R&D to develop advanced diagnostic tools, including real-time PCR and point-of-care solutions, to meet the growing demand for rapid, accurate testing. Strategic collaborations with healthcare providers and research institutions enhance market penetration, while direct-to-consumer sales channels, such as e-commerce platforms, improve accessibility. Emphasis on product differentiation, consumer education, and comprehensive marketing strategies fosters market growth and strengthens brand loyalty in the evolving Monkeypox Diagnosis Market landscape.

Key Market Players

Abbott Laboratories
Aegis Sciences Corporation
Applied DNA Sciences, Inc.
Becton, Dickinson and Company
BioGX
bioMerieux SA
Bio-Rad Laboratories, Inc.
CerTest Biotec
Creative Biogene
Danaher Corporation
Flow Health
Laboratory Corporation of America Holdings
Mayo Clinic Laboratories
Quest Diagnostics, Inc.
Thermo Fisher Scientific Inc.

Market Segmentation

By Diagnostic Test

Antigen Detection Test
Molecular Test

By Sample

Urine
Whole Blood
Skin lesion Specimen

By Region

North America
Latin America
Europe
South Asia & Oceania
East Asia
The Middle East & Africa

Product Code: PMRREP34755

1. Executive Summary

1.1. Global Monkeypox (mpox) Diagnosis Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Diagnostic Test Adoption Analysis
3.2. Disease Epidemiology- Monkeypox (mpox)
3.3. Regulatory Landscape
3.4. Value Chain Analysis
3.5. PESTLE Analysis
3.6. Porter's Five Force Analysis
3.7. Promotional Strategies, By Key Players

4. Global Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
- 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
4.3. Global Monkeypox (mpox) Diagnosis Market Outlook: Diagnostic Test
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Diagnostic Test, 2019-2023
- 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
  - 4.3.3.1. Antigen Detection Test
  - 4.3.3.2. Molecular Test
- 4.3.4. Market Attractiveness Analysis: Diagnostic Test
4.4. Global Monkeypox (mpox) Diagnosis Market Outlook: Sample
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn) Analysis, By Sample, 2019-2023
- 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
  - 4.4.3.1. Urine
  - 4.4.3.2. Whole Blood
  - 4.4.3.3. Skin Lesion Specimen
  - 4.4.3.4. Others
- 4.4.4. Market Attractiveness Analysis: Sample

5. Global Monkeypox (mpox) Diagnosis Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 6.2.1. By Country
- 6.2.2. By Diagnostic Test
- 6.2.3. By Sample
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
- 6.4.1. Antigen Detection Test
- 6.4.2. Molecular Test
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
- 6.5.1. Urine
- 6.5.2. Whole Blood
- 6.5.3. Skin Lesion Specimen
- 6.5.4. Others
6.6. Market Attractiveness Analysis

7. Europe Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 7.2.1. By Country
- 7.2.2. By Diagnostic Test
- 7.2.3. By Sample
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
- 7.4.1. Antigen Detection Test
- 7.4.2. Molecular Test
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
- 7.5.1. Urine
- 7.5.2. Whole Blood
- 7.5.3. Skin Lesion Specimen
- 7.5.4. Others
7.6. Market Attractiveness Analysis

8. East Asia Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 8.2.1. By Country
- 8.2.2. By Diagnostic Test
- 8.2.3. By Sample
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
- 8.4.1. Antigen Detection Test
- 8.4.2. Molecular Test
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
- 8.5.1. Urine
- 8.5.2. Whole Blood
- 8.5.3. Skin Lesion Specimen
- 8.5.4. Others
8.6. Market Attractiveness Analysis

9. South Asia & Oceania Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 9.2.1. By Country
- 9.2.2. By Diagnostic Test
- 9.2.3. By Sample
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
- 9.4.1. Antigen Detection Test
- 9.4.2. Molecular Test
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
- 9.5.1. Urine
- 9.5.2. Whole Blood
- 9.5.3. Skin Lesion Specimen
- 9.5.4. Others
9.6. Market Attractiveness Analysis

10. Latin America Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 10.2.1. By Country
- 10.2.2. By Diagnostic Test
- 10.2.3. By Sample
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
- 10.4.1. Antigen Detection Test
- 10.4.2. Molecular Test
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
- 10.5.1. Urine
- 10.5.2. Whole Blood
- 10.5.3. Skin Lesion Specimen
- 10.5.4. Others
10.6. Market Attractiveness Analysis

11. Middle East & Africa Monkeypox (mpox) Diagnosis Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 11.2.1. By Country
- 11.2.2. By Diagnostic Test
- 11.2.3. By Sample
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2031
- 11.4.1. Antigen Detection Test
- 11.4.2. Molecular Test
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Sample, 2024-2031
- 11.5.1. Urine
- 11.5.2. Whole Blood
- 11.5.3. Skin Lesion Specimen
- 11.5.4. Others
11.6. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Share Analysis, 2023
12.2. Market Structure
- 12.2.1. Competition Intensity Mapping, By Market
- 12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Abbott Molecular, Inc.
  - 12.3.1.1. Overview
  - 12.3.1.2. Segments and Products
  - 12.3.1.3. Key Financials
  - 12.3.1.4. Market Developments
  - 12.3.1.5. Market Strategy
- 12.3.2. Laboratory Corporation of America (Labcorp)
- 12.3.3. Cue Health, Inc.
- 12.3.4. Quest Diagnostics Nichols Institute
- 12.3.5. Cepheid
- 12.3.6. DiaCarta, Inc.
- 12.3.7. Roche Molecular Systems, Inc.
- 12.3.8. Meridian Biosciences
- 12.3.9. Vazyme International LLC
- 12.3.10. Siemens Healthcare
- 12.3.11. MedTech Zone
- 12.3.12. Creative Biogene
- 12.3.13. Transasia diagnostics
- 12.3.14. JOYSBIO (Tianjin) Biotechnology Co., Ltd
- 12.3.15. Daan Gene Co., Ltd.
- 12.3.16. BD
- 12.3.17. CERTEST BIOTEC

13. Appendix

13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations